Europe medical plastics market was valued at $11.0 billion in 2024 and is projected to reach $22.8 billion by 2035, growing at a CAGR of 6.6% during the forecast period (2025–2035). A shift towards minimally invasive surgeries is increasing the demand for medical plastics in the European market.
Browse the full report description of “Europe Medical Plastics Market Size, Share & Trends Analysis Report by Plastic Type (Traditional Plastics (Polyvinylchloride (PVC), Polyethylene (PE), Polystyrene (PS), Polypropylene (PP), and Silicone), Engineered Plastics (Nylon, Polycarbonate (PC), Polyoxymethylene (POM), Acrylonitrile butadiene styrene (ABS), Polymethylmethacrylate (PMMA), Polyphenylene Oxide (PPO), and Others), and by Application (Disposables, Diagnostic Instruments, Catheters and Syringes, Implants, Dental Tools, Surgical Instruments, Medical Bags, Drug Delivery Devices, and Others), Forecast Period (2025-2035)” of https://www.omrglobal.com/industry-reports/europe-medical-plastics-market
According to Eurostat, the vast majority of cholecystectomies (gallbladder removal surgeries) in EU countries were performed laparoscopically in 2022, with the share ranging from approximately 79% in Bulgaria to 96% in the Netherlands, highlighting the widespread adoption of minimally invasive surgical techniques across Europe that rely heavily on medical plastic-based surgical instruments.
As medical plastic is lightweight, flexible & durable and most importantly, it allows complex geometrical manufacturing which is not possible in other materials. Minimally invasive surgeries require tools to enter the body through "keyhole" incisions, in which metal surgical equipment are not used as it has structural and manufacturing limits, and to overcome that, high-performance plastics (including PEEK and LCP) are used to be injection-molded into microscopic, complex components that provide the necessary strength and dimensional stability which is required for high-precision surgical instruments.
Medical plastics, such as polycarbonate, polypropylene, PEEK, and medical-grade elastomers, provide the necessary optical clarity, dimensional stability, and sterilization compatibility which is required in diagnostic applications, including in vitro diagnostic (IVD) devices and imaging systems.
According to the European Commission’s SAMIRA Action Plan, around 500 million radiological imaging procedures are performed annually in the EU, with a growing share used for interventional guidance. To avoid imaging artefacts caused by metal, this trend is driving increased use of high-performance medical plastics that enable clear, real-time visualization during minimally invasive procedures.
Apart from this, the widespread use of high-frequency electrosurgery in minimally invasive procedures is driving demand for medical plastics, as materials such as PEEK and PPSU provide inherent electrical insulation. Unlike metal instruments, these plastics prevent stray electrical energy and reduce the risk of accidental tissue damage, making them essential for safer and more reliable MIS devices.
Recent Business Development in the Medical Plastics Market
Market Coverage
Key questions addressed by the report.
Europe Medical Plastics Market Report Segment
By Plastic Type
Europe Medical Plastics Market Report Segment by Region
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/europe-medical-plastics-market